Feline babesiosis

Journal of Veterinary Emergency and Critical Care

Volumn 20, Issue 1, 2010, Pages 90-97

  Ayoob, Ashley L ^a   Prittie, Jennifer ^a   Hackner, Susan G ^a  

^a ANIMAL MEDICAL CENTER   (United States)

Author keywords

Blood borne parasite; Feline hemoprotozoa; Piroplasm

Indexed keywords

BABESIA; FELIDAE;

ANTIPROTOZOAL AGENT;

ANIMAL; ANIMAL DISEASE; BABESIA; BABESIOSIS; CAT; CAT DISEASE; HOSPITALIZATION; ISOLATION AND PURIFICATION; LIFE CYCLE; MORTALITY; PATHOGENICITY; PROGNOSIS; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ANIMALS; ANTIPROTOZOAL AGENTS; BABESIA; BABESIOSIS; CAT DISEASES; CATS; LIFE CYCLE STAGES; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77953379071     PISSN: 14793261     EISSN: 14764431     Source Type: Journal    
DOI: 10.1111/j.1476-4431.2009.00493.x     Document Type: Review

References (46)

1. Taboada J, Lobetti R. Babesiosis. Infectious Diseases of the Dog and Cat 2006, 722-735. Greene C, In, ed, 3rd ed, St Louis, WB Saunders Co, pp
2. Shaw SE, Birtles RJ, Day MJ. Arthropod-transmitted infectious diseases of cats. J Feline Med Surg 2001, 3:193-209.
3. Jacobson L, Schoeman T, Lobetti R. A survey a feline babesiosis in South Africa. J S Afr Vet Assoc 2000, 71((4)):222-228.
4. Lopez-Rebollar LM, Penzhorn BL, deWaal DT. A possible new piroplasm in lions from the Republic of South Africa. J Wildl Dis 1999, 35:82-85.
5. Baneth G, Kenny MJ, Tasker S. Infection with a proposed new subspecies of Babesia canis, Babesia canis subsp. presentii in domestic cats. J Clin Microbiol 2004, 42((1)):99-105.
6. Yabsley MJ, Murphy SM, Cunningham MW. Molecular detection and characterization of Cytauxzoon felis and a Babesia species in cougars from Florida. J Wildl Dis 2006, 42((2)):366-374.
7. Moik K, Gothe R. Babesia infections of felids and a report on a case in Germany. Tierarz Praxis Ausg Klein Heim 1997, 25:532-535.
8. Futter G, Belonje P. Studies on feline babesiosis. I. Historical review. J S Afr Vet Assoc 1980, 51((2)):105-106.
9. Futter G, Belonje P. Studies on feline babesiosis. 2. Clinical observations. J S Afr Vet Assoc 1980, 51((3)):143-146.
10. Futter G, Belonje P, van den Berg A. Studies on feline babesiosis. 3. Haematologic findings. J S Afr Vet Assoc 1980, 51((4)):1271-1280.
11. Futter G, Belonje P, van den Berg A. Studies on feline babesiosis. 4. Chemical pathology; macroscopic and microscopic post mortem findings. J S Afr Vet Assoc 1980, 52((1)):5-14.
12. Schoeman T, Lobetti R, Jacobson L. Feline babesiosis: signalment, clinical pathology and concurrent infections. J S Afr Vet Assoc 2001, 72((1)):4-11.
13. Criado-Fornelio A, Martinez-Marcos A, Bulin-Sarana A. Presence of Mycoplasma haemofelis, Mycoplasma haemominutum, and piroplasmids in cats from Southern Europe: a molecular study. Vet Microbiol 2003, 93:307-317.
14. Stewart CG, Hackett KJ, Collett MG. An unidentified Babesia of the domestic cat (Felis Domesticus). J S Afr Vet Assoc 1980, 51((4)):219-221.
15. Bourdeau P. Feline babesiosis. Point Vet 1996, 27:947-953.
16. Jittapalapong S, Jansawan W. Preliminary survey on blood parasites of cats in Bangkhen district area. Natural Sciences 1993, 27:330-335.
17. Penzhorn BL, Kjemtrup AM, Lopez-Rebollar LM. Babesia leo n. sp. from lions in the Kruger National Park, South Africa, and its relation to other small piroplasms. J Parasitol 2001, 87((3)):681-685.
18. Penzhorn BL, Stylianides E, Coetzee MA. A focus of feline babesiosis at Kaapschehoop on the Mpumalanga escarpment. J S Afr Vet Assoc 1999, 70((2)):60.
19. Bosman AM, Venter EH, Penzhorn BL. Occurrence of Babesia felis and Babesia leo in various wild felid species and domestic cats in Southern Africa, based on reverse line blot analysis. Vet Parasitol 2007, 144:33-38.
20. Kuttler KL. World-wide impact of babesiosis. Babesiosis of Domestic Animals and Man 1988, 1-22. Ristic M. In, ed, Boca Raton, CRC Press, pp
21. Pappalardo BL, Correa MT, York CC. Epidemiologic evaluation of the risk factors associated with exposure and seroreactivity to Bartonella vinsonii in dogs. Am J Vet Res 1997, 58((5)):467-471.
22. Friedhoff KT. Transmission of Babesia. Babesiosis of domestic animals and man 1988, 23-52. Ristic M. In, ed, Boca Raton, CRC Press, pp
23. Igarashi I, Aikawa M, Kreier JP. Host cell-parasite interaction in babesiosis. Babesiosis of domestic animals and man 1988, 53-69. Ristic M, In, ed, Boca Raton, CRC Press, pp
24. Uilenberg G. Babesia- A historical overview. Vet Parasitol 2006, 138:3-10.
25. Taboada J, Merchant SR. Babesiosis of companion animals and man. Vet Clin North Am Small Anim Pract 1991, 21((1)):103-123.
26. Wright IG, Goodger BV. Pathogenesis of babesiosis. Babesiosis of Domestic Animals and Man 1988, 99-118. Ristic M, In, ed, Boca Raton, CRC Press, pp
27. Clark IA. Correlation between susceptibility to malaria and babesia parasites and to endotoxicity. Trans R Soc Trop Med Hyg 1982, 76:4-7.
28. Otto CM, Rawlings CA. Tumor necrosis factor production in cats in response to lipopolysaccharide: an in vivo and in vitro study. Vet Immun Immunopathol 1995, 49:183-188.
29. Potgieter FT. Chemotherapy of Babesia felis infection: efficacy of certain drugs. J S Afr Vet Assoc 1981, 52((4)):289-293.
30. Makinde MO, Bobade PA. Osmotic fragility of erythrocytes in clinically normal dogs and dogs with parasites. Res Vet Sci 1994, 57:343-348.
31. Foreyt WJ. Diagnostic parasitology. Vet Clin North Am Small Anim Pract 1989, 19:979-1000.
32. Bobade PA, Oduye OO, Aghomo HO. Prevalence of antibodies against Babesia canis in dogs in an endemic area. Rev Elev Med Vet Pays Trop 1989, 42:211-217.
33. Martinod S, Laurent N, Mareau Y. Resistance and immunity of dogs against Babesia canis in an endemic area. Vet Parasitol 1986, 19((3-4)):245-254.
34. Penzhorn BL, Lewis BD, Lopez-Rebollar LM. Screening of five drugs for efficacy against Babesia felis in experimentally infected cats. J S Afr Vet Assoc 2000, 71((1)):53-57.
35. Kuttler KL. Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis. J Am Vet Med Assoc 1980, 176:1103-1108.
36. Penzhorn BL, Lewis BD, de Waal DT. Sterilisation of Babesia canis infections by imidocarb alone or in combination with diminazene. J S Afr Vet Assoc 1995, 66:157-159.
37. Jacobson L, Reyers F, Berry W. Changes in haematocrit after treatment of uncomplicated babesiosis: a comparison between diminazene and trypan blue, and an evaluation of the influence of parasitemia. J S Afr Vet Assoc 1996, 67((2)):77-82.
38. Vannier E, Gewurz BE, Krause PJ. Human babesiosis. Infect Dis Clin N Am 2008, 22:469-488.
39. Birkenheuer A, Levy M, Breitschwerdt E. Efficacy of combined atovaquone and azithromycin for therapy of chronic Babesia gibsoni (Asian genotype) infections in dogs. J Vet Intern Med 2004, 18((4)):494-498.
40. Hughes WT, Helieh SO. Successful prevention and treatment of babesiosis with atovaquone. J Infect Dis 1995, 172:1042-1046.
41. Weiss LM, Wittner M, Wasserman S. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J Infect Dis 1993, 168:1289-1292.
42. Matsuu A, Koshida Y, Kawahara M. Efficacy of atovaquone in vivo and in vitro. Vet Parasitol 2004, 124:9-18.
43. Wulansari R, Wijaya A, Ano H. Lymphocyte subsets and specific IgG antibody levels in clindamycin-treated and untreated dogs experimentally infected with Babesia gibsoni. J Vet Med Sci 2003, 65:579-584.
44. Wulansari R, Wijaya A, Ano H. Clindamycin in the treatment of Babesia gibsoni infection in dogs. J Am Anim Hosp Assoc 2003, 39((6)):558-562.
45. Vercammen F, Deken R, Maes L. Prophylactic treatment of experimental canine babesiosis (Babesia canis) with doxycycline. Vet Parasitol 1996, 66((3-4)):251-255.
46. Suzuki K, Wakabayashi H, Takahashi M. A possible treatment strategy and clinical factors to estimate the treatment response in Babesia gibsoni infection. J Vet Med Sci 2007, 69((5)):563-568.